臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jen chang ko"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 131-180 / 290 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-03-11T08:34:19Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:34:19Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:34:19Z	Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study	Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:19Z	Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study	Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:19Z	Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study	Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏	2021-03-11T08:34:19Z	Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study	Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏	2021-03-11T08:34:18Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:18Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:18Z	Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells	Jen-Chang Ko;Chen J.-C.;Chen T.-Y.;Yen T.-C.;Ma P.-F.;Lin Y.-C.;Wu C.-H.;Peng Y.-S.;Zheng H.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:18Z	Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells	Jen-Chang Ko;Chen J.-C.;Chen T.-Y.;Yen T.-C.;Ma P.-F.;Lin Y.-C.;Wu C.-H.;Peng Y.-S.;Zheng H.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:18Z	Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells	Chen J.-C.;Jen-Chang Ko;Yen T.-C.;Chen T.-Y.;Lin Y.-C.;Ma P.-F.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:18Z	Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells	Chen J.-C.;Jen-Chang Ko;Yen T.-C.;Chen T.-Y.;Lin Y.-C.;Ma P.-F.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Yen T.-C.; Chen T.-Y.; Lin Y.-C.; Ma P.-F.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:17Z	Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study	Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Jen-Chang Ko;Lee L.-N.; Meng-Rui Lee; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N.
臺大學術典藏	2021-03-11T08:34:17Z	Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study	Lee M.-R.;Lee C.-H.;Wang J.-Y.;Lee S.-W.;Jen-Chang Ko;Lee L.-N.; Meng-Rui Lee; Lee C.-H.; Wang J.-Y.; Lee S.-W.; JEN-CHANG KO; Lee L.-N.
臺大學術典藏	2021-03-11T08:34:17Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-03-11T08:34:17Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-03-11T08:34:17Z	Downregulation of xeroderma pigmentosum complementation group c expression by 17-allylamino-17-demethoxygeldanamycin enhances bevacizumab-induced cytotoxicity in human lung cancer cells	Chen J.-C.;Jen-Chang Ko;Taso Y.-C.;Cheng H.-H.;Chen T.-Y.;Yen T.-C.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Taso Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:17Z	Downregulation of xeroderma pigmentosum complementation group c expression by 17-allylamino-17-demethoxygeldanamycin enhances bevacizumab-induced cytotoxicity in human lung cancer cells	Chen J.-C.;Jen-Chang Ko;Taso Y.-C.;Cheng H.-H.;Chen T.-Y.;Yen T.-C.;Lin Y.-W.; Chen J.-C.; JEN-CHANG KO; Taso Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:16Z	Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study	Lee M.-R.;Huang H.-L.;Chen L.-C.;Yang H.-C.;Jen-Chang Ko;Cheng M.-H.;Chong I.-W.;Lee L.-N.;Wang J.-Y.;Dimopoulos G.; MENG-RUI LEE; Huang H.-L.; Lun-Che Chen; HAN-CHING YANG; JEN-CHANG KO; Cheng M.-H.; Chong I.-W.; Lee L.-N.; Wang J.-Y.; Dimopoulos G.
臺大學術典藏	2021-03-11T08:34:16Z	Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study	Lee M.-R.;Huang H.-L.;Chen L.-C.;Yang H.-C.;Jen-Chang Ko;Cheng M.-H.;Chong I.-W.;Lee L.-N.;Wang J.-Y.;Dimopoulos G.; MENG-RUI LEE; Huang H.-L.; Lun-Che Chen; HAN-CHING YANG; JEN-CHANG KO; Cheng M.-H.; Chong I.-W.; Lee L.-N.; Wang J.-Y.; Dimopoulos G.
臺大學術典藏	2021-03-11T08:34:16Z	Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review	Lee M.-R.;Chang L.-Y.;Jen-Chang Ko;Wang H.-C.;Huang Y.-W.; MENG-RUI LEE; LIH-YU CHANG; JEN-CHANG KO; Wang H.-C.; Huang Y.-W.
臺大學術典藏	2021-03-11T08:34:16Z	Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review	Lee M.-R.;Chang L.-Y.;Jen-Chang Ko;Wang H.-C.;Huang Y.-W.; MENG-RUI LEE; LIH-YU CHANG; JEN-CHANG KO; Wang H.-C.; Huang Y.-W.
臺大學術典藏	2021-03-11T08:34:16Z	Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells	Jen-Chang Ko;Chen J.-C.;Yen T.-C.;Chen T.-Y.;Ma P.-F.;Lin Y.-C.;Cheng H.-H.;Taso Y.-C.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Yen T.-C.; Chen T.-Y.; Ma P.-F.; Lin Y.-C.; Cheng H.-H.; Taso Y.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:16Z	Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells	Jen-Chang Ko;Chen J.-C.;Yen T.-C.;Chen T.-Y.;Ma P.-F.;Lin Y.-C.;Cheng H.-H.;Taso Y.-C.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Yen T.-C.; Chen T.-Y.; Ma P.-F.; Lin Y.-C.; Cheng H.-H.; Taso Y.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:15Z	Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer dissemination	Kuo M.-H.; Lee A.-C.; Hsiao S.-H.; Lin S.-E.; Chiu Y.-F.; Yang L.-H.; Yu C.-C.; Chiou S.-H.; Huang H.-N.; JEN-CHANG KO; Chou Y.-T.
臺大學術典藏	2021-03-11T08:34:15Z	Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort	SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-11T08:34:15Z	Effect of β-Blocker in Treatment-Naive Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs	Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Shih J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Lee C.-H.; JEN-CHANG KO; LIH-YU CHANG; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-11T08:34:15Z	Effect of β-Blocker in Treatment-Naive Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs	Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Shih J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Lee C.-H.; JEN-CHANG KO; LIH-YU CHANG; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-03-11T08:34:14Z	Capsaicin Acts Through Reducing P38 MAPK-Dependent Thymidylate Synthase Expression to Enhance 5-Fluorouracil-Induced Cytotoxicity in Human Lung Cancer Cells	Tung C.-L.; Chen J.-C.; JEN-CHANG KO; Liu L.-L.; Chien C.-C.; Huang I.-H.; Tsao Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:29:45Z	Lobar bronchioloalveolar carcinoma: an ultrasound study.	JEN-CHANG KO; Yang P.C.; Luh K.T.; Kuo S.H.; Chang D.B.; Yu C.J.
臺大學術典藏	2021-03-11T08:29:45Z	Superior vena cava syndrome: Rapid histologic diagnosis by ultrasound- guided transthoracic needle aspiration biopsy	JEN-CHANG KO; Yang P.-C.; Yuan A.; Chang D.-B.; Yu C.-J.; Wu H.-D.; Lee L.-N.; Kuo S.-H.; Luh K.-T.
臺大學術典藏	2021-03-11T08:29:44Z	Panhypopituitarism caused by solitary parasellar metastasis from lung cancer	JEN-CHANG KO; Yang P.-C.; Huang T.-S.; Yeh K.-H.; Kuo S.-H.; Luh K.T.
臺大學術典藏	2021-03-11T08:29:44Z	Ultrasonographic evaluation of peridiaphragmatic lesions: A prospective study	JEN-CHANG KO; Yang P.-C.; Chang D.-B.; Yu C.-J.; Lee L.-N.; Kuo S.-H.; Luh K.-T.
臺大學術典藏	2021-03-11T08:29:44Z	Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion	Lee L.-N.; Luh K.-T.; Yang P.-C.; Chang D.-B.; Yu C.-J.; JEN-CHANG KO; Liaw Y.-S.; Wu R.-G.
臺大學術典藏	2021-03-11T08:29:43Z	Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells	Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:29:43Z	Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells	Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:29:43Z	Disseminated coccidioidomycosis [8]	Wang C.-Y.;Jerng J.-S.;Jen-Chang Ko;Lin M.-F.;Hsiao C.-H.;Lee L.-N.;Hsueh P.-R.;Kuo S.-H.; Wang C.-Y.; Jerng J.-S.; JEN-CHANG KO; Lin M.-F.; Hsiao C.-H.; Lee L.-N.; Hsueh P.-R.; Kuo S.-H.
臺大學術典藏	2021-03-11T08:29:43Z	Disseminated coccidioidomycosis [8]	Wang C.-Y.;Jerng J.-S.;Jen-Chang Ko;Lin M.-F.;Hsiao C.-H.;Lee L.-N.;Hsueh P.-R.;Kuo S.-H.; Wang C.-Y.; Jerng J.-S.; JEN-CHANG KO; Lin M.-F.; Hsiao C.-H.; Lee L.-N.; Hsueh P.-R.; Kuo S.-H.
臺大學術典藏	2021-03-11T08:29:43Z	Dual and opposing roles of ERK in regulating G1 and S-G 2/M delays in A549 cells caused by hyperoxia	Jen-Chang Ko;Wang Y.-T.;Yang J.-L.; JEN-CHANG KO; Wang Y.-T.; Yang J.-L.
臺大學術典藏	2021-03-11T08:29:43Z	Dual and opposing roles of ERK in regulating G1 and S-G 2/M delays in A549 cells caused by hyperoxia	Jen-Chang Ko;Wang Y.-T.;Yang J.-L.; JEN-CHANG KO; Wang Y.-T.; Yang J.-L.
臺大學術典藏	2021-03-11T08:29:43Z	The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer	Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:29:43Z	The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer	Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:29:42Z	The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells	JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:29:42Z	Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells	JEN-CHANG KO; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:29:42Z	Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells	Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Jheng M.-Y.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:29:42Z	Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells	Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Jheng M.-Y.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:29:41Z	Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2	Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:29:41Z	Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2	Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:29:41Z	Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation	Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHANG KO; Lin Y.-W.
臺大學術典藏	2021-03-11T08:29:41Z	Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells	Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W.

顯示項目 131-180 / 290 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51933210 線上人數 : 998 教育部委託研究計畫計畫執行:國立臺灣大學圖書館